Oncostellae
PrivateLast Round
Grant
Jul 1, 2025
Est. Valuation
$18.85M
Total Funding Raised
$3.25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Oncostellae is a biotechnology company that develops small-molecule drugs for the treatment of oncology and inflammatory/autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oncostellae Comparables
Compare Oncostellae with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ability Pharmaceuticals | 85% | |
| Leukos Biotech | 84% | |
| Palobiofarma S.L. | 83% |
Oncostellae Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2025 | ||||
| VC Round | Mar 18, 2024 | ||||
| VC Round | Jul 5, 2023 | ||||
| VC Round | Nov 22, 2022 | ||||
| VC Round | Jun 1, 2019 | ||||
Series A | Jul 23, 2017 |
Key People
Founding team and executive leadership
Oncostellae Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noso Capital | VC Round |
| Inveready | VC Round, Seed, Series A |
| Unirisco Galicia | VC Round, Series A |
| Center for Technological Development and Innovation | VC Round, Grant |
| Xesgalicia | VC Round, Seed, Series A |
| Fitalent | VC Round |
| Capital Cell | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 4132% MoM, from 38 to 1.6K.
- Mar 18, 2024
$540K raised from biotechsmartcapital, Noso Capital, and Center for Technological Development and Innovation.
Oncostellae Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Oncostellae's valuation, stock price, and market status.
Is Oncostellae a public or private company?
Oncostellae is a private company.
What is the current stock price of Oncostellae?
Oncostellae is a private company with no public stock price. No recent secondary market data is available.
How much is Oncostellae worth (valuation)?
Oncostellae's valuation is estimated at $18.9M based on funding round data.
Can I buy Oncostellae stock?
Oncostellae shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Oncostellae's last funding round?
Oncostellae's most recent funding round was Grant on November 22, 2022.
Who are the main investors in Oncostellae?
Key investors in Oncostellae include Noso Capital.
Will Oncostellae IPO soon?
No public IPO plans have been announced for Oncostellae.
How can I track Oncostellae secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oncostellae's secondary market activity and sign up for updates.